SLC5A2 and atrial fibrillation: The crude incidence rate of AF was 8.37 (95% CI, 7.01–9.99) and 11.79 (95% CI, 11.03–12.61) events per 1,000 PY for SGLT2 inhibitor users and DPP4 inhibitor users, respectively.